Get started
Author

C Montero-Vilchez

Observed names: C Montero Vilchez, C Montero Vílchez, CAROLINA MONTERO VILCHEZ
OpenAlex ID: A5023856418
4CPS-218 TNF gene polymorphisms predictors of response to anti-TNF drugs in patients diagnosed with moderate-severe psoriasis
2023 · C Membrive-Jimenez, C Zuñiga, et al. · Section 4: Clinical pharmacy services · 1
PDF
6ER-028 Assessment of symptoms and signs severity in psoriasis patients
2023 · MI Archilla Amat, C Montero Vílchez, et al. · 1
PDF
5PSQ-003 Impact of pharmacist interventions in elderly patients with polypharmacy
2025 · C Montero-Vilchez, MDM García-Valdés, et al.
PDF
5PSQ-116 Real-world persistence with guselkumab among adults with psoriatic arthritis
2024 · C Montero-Vilchez, MI Archilla Amat, et al. · Section 5: Patient safety and quality assurance
PDF
4CPS-150 Pharmaceutical interventions in obese patients in haematopoietic stem cell transplantation
2024 · C Montero-Vilchez, S Cano Dominguez, et al. · Section 4: Clinical pharmacy services
PDF
Comparación Indirecta De La Eficacia De Bimekizumab, Ixekizumab Y Brodalumab En El Tratamiento De La Psoriasis En Placas.
2024 · CARMEN LUCÍA MUÑOZ CID, MARIA ISABEL SIERRA TORRES, et al. · Sociedad Española de Farmacia Hospitalaria eBooks
2SPD-009 Avoided costs from the inclusion of breast cancer patients in clinical trials
2023 · AM Valle Díaz de la Guardia, S Sadyrbaeva Dolgova, et al.
PDF
5PSQ-120 Analysis of the pharmaceutical interventions performed on onco-haematological patients through an onco-haematology pharmacy consultation
2023 · C Alarcon-Payer, A Martín Roldan, et al. · Section 5: Patient safety and quality assurance
PDF
6ER-017 Structured objective clinical evaluation for pharmacy students on internships at the hospital
2023 · AM Valle Díaz de la Guardia, S Sadyrbaeva Dolgova, et al.
PDF
4CPS-015 Role of clinical pharmacist in the optimisation of nirmatrelvir/ritonavir prescription in the emergency department
2023 · MDM Sánchez Suárez, A Martín Roldan, et al. · Section 4: Clinical pharmacy services
PDF
5PSQ-138 Chemotherapy errors detected during pharmaceutical validation
2023 · MC Sánchez Argaiz, MJ Gándara Ladrón de Guevara, et al. · Section 5: Patient safety and quality assurance
PDF
4CPS-050 Analysis of real-life use of ibrutinib after relapse to conventional chemotherapy in patients with chronic lymphocytic leukaemia
2023 · A Martín Roldán, MDM Sanchez Suarez, et al. · Section 4: Clinical pharmacy services
PDF
2SPD-017 Telepharmacy and home delivery programme for outpatients through the community pharmacy
2023 · MR Cantudo Cuenca, M Arenas Jimenez, et al.
PDF
6ER-005 Effects of adherence to the Mediterranean diet in patients with autoimmune diseases
2023 · A Martín Roldán, MDM Sanchez Suarez, et al.
PDF
4CPS-011 Clinical and economic impact of pharmacist antimicrobial interventions in a small hospital
2023 · MR Cantudo Cuenca, M Arenas Jiménez, et al.
PDF
5PSQ-009 Effectiveness and safety of monoclonal antibody switching in migraine patients
2023 · MI Archilla Amat, C Montero Vílchez, et al.
PDF
5PSQ-091 Dalbavancin administration in outpatients to reduce hospital stay in selected patients
2022 · C Montero-Vilchez, MP Aznarte-Padial, et al. · Section 5: Patient safety and quality assurance
PDF
5PSQ-152 Effectiveness and safety of erenumab in migraine prophylaxis
2022 · C Montero-Vilchez, A Martin-Roldan, et al. · Section 5: Patient safety and quality assurance
PDF
Works count: 18
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type